Download as PDF
74520
Federal Register / Vol. 77, No. 241 / Friday, December 14, 2012 / Notices
200.402(a)(2) and (6), permit
consideration of the scheduled matter at
the Closed Meeting.
Commissioner Walter, as duty officer,
voted to consider the item listed for the
Closed Meeting in closed session, and
determined that no earlier notice thereof
was possible.
At times, changes in Commission
priorities require alterations in the
scheduling of meeting items. For further
information and to ascertain what, if
any, matters have been added, deleted
or postponed, please contact the Office
of the Secretary at (202) 551–5400.
Dated: December 12, 2012.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2012–30326 Filed 12–12–12; 4:15 pm]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[File No. 500–1]
In the Matter of the Hartcourt
Companies, Inc., Hawksdale Financial
Visions, Inc. (n/k/a Advanced Medical
Institute, Inc.), Healthcare Providers
Direct, Inc., Heartland Oil & Gas Corp.,
Hellenic Solutions Corp., and HIV–
VAC, Inc. (n/k/a Grupo International,
Inc.); Order of Suspension of Trading
mstockstill on DSK4VPTVN1PROD with
December 12, 2012.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of The
Hartcourt Companies, Inc. because it
has not filed any periodic reports since
the period ended November 30, 2009.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Hawksdale
Financial Visions, Inc. (n/k/a Advanced
Medical Institute, Inc.) because it has
not filed any periodic reports since the
period ended December 31, 2009.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Healthcare
Providers Direct, Inc. because it has not
filed any periodic reports since
September 30, 2008.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Heartland
Oil & Gas Corp. because it has not filed
any periodic since the period ended
June 30, 2008.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
VerDate Mar<15>2010
16:41 Dec 13, 2012
Jkt 229001
concerning the securities of Hellenic
Solutions Corp. because it has not filed
any periodic reports since the period
ended September 30, 2010.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of HIV–VAC,
Inc. (n/k/a Grupo International, Inc.)
because it has not filed any periodic
reports since the period ended
December 31, 2010.
The Commission is of the opinion that
the public interest and the protection of
investors require a suspension of trading
in the securities of the above-listed
companies.
Therefore, it is ordered, pursuant to
Section 12(k) of the Securities Exchange
Act of 1934, that trading in the
securities of the above-listed companies
is suspended for the period from 9:30
a.m. EST on December 12, 2012,
through 11:59 p.m. EST on December
26, 2012.
By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2012–30301 Filed 12–12–12; 4:15 pm]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[File No. 500–1]
Encore Clean Energy, Inc., Energy &
Engine Technology Corp., Equity
Media Holdings Corporation,
eTotalSource, Inc., Extensions, Inc.,
Firepond, Inc., and GNC Energy
Corporation; Order Withdrawing
Trading Suspension as to Extensions,
Inc.
December 12, 2012.
The Securities and Exchange
Commission hereby withdraws the
trading suspension order as to the
securities of Extensions, Inc. (‘‘EXTI’’)
entered November 29, 2012 (‘‘November
29, 2012 Order’’).
This order shall be effective
immediately.
The remainder of the November 29,
2012 Order remains in full force and
effect according to its original terms.
By the Commission.
Kevin M. O’Neill,
Deputy Secretary.
[FR Doc. 2012–30299 Filed 12–12–12; 4:15 pm]
BILLING CODE 8011–01–P
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–68393; File No. SR–Phlx–
2012–134]
Self-Regulatory Organizations;
NASDAQ OMX PHLX LLC; Notice of
Filing and Immediate Effectiveness of
a Proposal with Respect to the
Authority of the Exchange or Nasdaq
Options Services LLC (‘‘NOS’’) To
Cancel Options Orders when a
Technical or System Issue Occurs and
To Describe the Operation of an Error
Account for NOS
December 10, 2012.
Pursuant to Section 19(b)(1) 1 of the
Securities Exchange Act of 1934 (the
‘‘Act’’) 2 and Rule 19b–4 thereunder,3
notice is hereby given that, on
November 30, 2012, NASDAQ OMX
PHLX LLC (‘‘PHLX’’ or ‘‘Exchange’’)
filed with the Securities and Exchange
Commission (the ‘‘Commission’’) the
proposed rule change as described in
Items I and II below, which Items have
been prepared by the self-regulatory
organization. The Commission is
publishing this notice to solicit
comments on the proposed rule change
from interested persons.
I. Self-Regulatory Organization’s
Statement of the Terms of Substance of
the Proposed Rule Change
The Exchange is filing a proposal with
respect to the authority of the Exchange
or NOS to cancel options orders when
a technical or system issue occurs and
to describe the operation of an error
account for NOS. The text of the
proposed rule change is available at
http://
nasdaqomxphlx.cchwallstreet.com, at
PHLX’s principal office, and at the
Commission’s Public Reference Room.
II. Self-Regulatory Organization’s
Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule
Change
In its filing with the Commission, the
Exchange included statements
concerning the purpose of, and basis for,
the proposed rule change and discussed
any comments it received on the
proposed rule change. The text of those
statements may be examined at the
places specified in Item IV below. The
Exchange has prepared summaries, set
forth in sections A, B, and C below, of
the most significant parts of such
statements.
1 15
U.S.C.78s(b)(1).
U.S.C. 78a.
3 17 CFR 240.19b–4.
2 15
E:\FR\FM\14DEN1.SGM
14DEN1